prof. MUDr. Michael Doubek, Ph.D.
Head of the research group, Michael Doubek Research Group: Genetic predisposition to hematologic disorders Neuroscience
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 2144, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 866
2021
-
Real-world evidence on therapeutic strategies and treatment-sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European research initiative on CLL
Year: 2021, type: Conference abstract
-
RGDS-Modified Superporous Poly(2-Hydroxyethyl Methacrylate)-Based Scaffolds as 3D In Vitro Leukemia Model
International Journal of Molecular Sciences, year: 2021, volume: 22, edition: 5, DOI
-
Rituximab induces rapid blood repopulation by CLL cells mediated through their release from immune niches and complement exhaustion
Leukemia Research, year: 2021, volume: 111, edition: December 2021, DOI
-
Three-dimensional biomaterials as a tool for in vitro culture of leukemic B cells.
Year: 2021, type: Conference abstract
-
Význam použitia panelového NGS testovania u myelodysplastického syndrómu.
Year: 2021, type: Conference abstract
2020
-
Akutní lymfoblastická leukemie a význam nových léčiv pro navození remise - přemostění k alogenní transplantaci krvetvorných buněk
Hematologie a hematoonkologie v kazuistikách, edition: 1. vydání, year: 2020, number of pages: 5 s.
-
Akutní lymfoblastická leukemie s nálezem chromozomu Philadelphia a nové tyrosinkinázové inhibitory
Hematologie a hematoonkologie v kazuistikách, edition: 1. vydání, year: 2020, number of pages: 6 s.
-
Akutní myeloidní leukemie
Speciální onkologie, edition: 2. vydání, year: 2020
-
Analýza myeloproliferací pomocí sekvenování nové generace (MPN panel).
Year: 2020, type: Conference abstract
-
Blinatumomab vs historic standard-of-care treatment for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukaemia
European Journal of Haematology, year: 2020, volume: 104, edition: 4, DOI